Cargando…

Autophagy in Parkinson’s Disease

Parkinson’s disease (PD) is a devastating disease associated with accumulation of α-synuclein (α-Syn) within dopaminergic neurons, leading to neuronal death. PD is characterized by both motor and non-motor clinical symptoms. Several studies indicate that autophagy, an important intracellular degrada...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nechushtai, Lior, Frenkel, Dan, Pinkas-Kramarski, Ronit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604695/ https://www.ncbi.nlm.nih.gov/pubmed/37892117 http://dx.doi.org/10.3390/biom13101435

Ejemplares similares

Ras and autophagy in cancer development and therapy
por: Schmukler, Eran, et al.
Publicado: (2014)

APOE4 expression is associated with impaired autophagy and mitophagy in astrocytes
por: Eran, Schmukler, et al.
Publicado: (2021)

Neuregulin Promotes Incomplete Autophagy of Prostate Cancer Cells That Is Independent of mTOR Pathway Inhibition
por: Schmukler, Eran, et al.
Publicado: (2012)

Continuous treatment with FTS confers resistance to apoptosis and affects autophagy
por: Schmukler, Eran, et al.
Publicado: (2017)

Ras inhibition enhances autophagy, which partially protects cells from death
por: Schmukler, Eran, et al.
Publicado: (2013)

Autophagy is induced and modulated by cholesterol depletion through transcription of autophagy-related genes and attenuation of flux
por: Shapira, Keren E., et al.
Publicado: (2021)

Identification of Nucleolin as New ErbB Receptors- Interacting Protein
por: Di Segni, Ayelet, et al.
Publicado: (2008)

Disrupting the Oncogenic Synergism between Nucleolin and Ras Results in Cell Growth Inhibition and Cell Death
por: Schokoroy, Sari, et al.
Publicado: (2013)

Structure-Function Analysis of Nucleolin and ErbB Receptors Interactions
por: Farin, Keren, et al.
Publicado: (2009)

Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma
por: Goldshmit, Yona, et al.
Publicado: (2014)

Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
por: Wolfson, Eya, et al.
Publicado: (2018)

Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer
por: Wolfson, Eya, et al.
Publicado: (2016)

Chloroquine synergizes with FTS to enhance cell growth inhibition and cell death
por: Schmukler, Eran, et al.
Publicado: (2013)

Inhibition of Ras GTPases prevents Collagen‐Induced Arthritis by Reducing the Generation of Pathogenic CD4(+) T Cells and the Hyposialylation of Autoantibodies
por: Zayoud, Morad, et al.
Publicado: (2020)

Altered mitochondrial dynamics and function in APOE4-expressing astrocytes
por: Schmukler, Eran, et al.
Publicado: (2020)

Translational read-through promotes aggregation and shapes stop codon identity
por: Kramarski, Lior, et al.
Publicado: (2020)

Parkinson's Disease and Autophagy
por: Sánchez-Pérez, Ana María, et al.
Publicado: (2012)

The role of autophagy in Parkinson's disease☆
por: Zhang, Lei, et al.
Publicado: (2012)

The emerging role of autophagy in Parkinson's disease
por: Cheung, Zelda H, et al.
Publicado: (2009)

An Emerging Role for Phosphoinositides in the Pathophysiology of Parkinson’s Disease
por: Schechter, Meir, et al.
Publicado: (2021)

A Novel, Sensitive Assay for Behavioral Defects in Parkinson's Disease Model Drosophila
por: Shaltiel-Karyo, Ronit, et al.
Publicado: (2012)

Dysregulation of autophagy and mitochondrial function in Parkinson’s disease
por: Wang, Bao, et al.
Publicado: (2016)

Nutraceuticals as Modulators of Autophagy: Relevance in Parkinson’s Disease
por: Rakowski, Michał, et al.
Publicado: (2022)

Neuroinflammation and Autophagy in Parkinson’s Disease—Novel Perspectives
por: Minchev, Danail, et al.
Publicado: (2022)

Pathogenic Aspects and Therapeutic Avenues of Autophagy in Parkinson’s Disease
por: Kinet, Rémi, et al.
Publicado: (2023)

Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
por: Moors, Tim E., et al.
Publicado: (2017)

Chaperone-Mediated Autophagy and Mitochondrial Homeostasis in Parkinson's Disease
por: Yang, Ruixin, et al.
Publicado: (2016)

Autophagy and Its Association with Genetic Mutations in Parkinson Disease
por: Erekat, Nour S.
Publicado: (2022)

Deconvoluting the complexity of autophagy and Parkinson's disease for potential therapeutic purpose
por: Li, Jingjing, et al.
Publicado: (2015)

Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson’s Disease
por: Zhu, Zhou, et al.
Publicado: (2019)

Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2021)

Implication of Autophagy in Parkinson's Disease
por: González-Polo, Rosa Ana, et al.
Publicado: (2013)

Diversity in the Regulation of Autophagy and Mitophagy: Lessons from Parkinson's Disease
por: Chu, Charleen T.
Publicado: (2011)

The role of microglial autophagy in Parkinson’s disease
por: Zhu, Rui, et al.
Publicado: (2022)

Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
por: Wang, Zhifu, et al.
Publicado: (2023)

The Consequences of GBA Deficiency in the Autophagy–Lysosome System in Parkinson’s Disease Associated with GBA
por: Pradas, Eddie, et al.
Publicado: (2023)

LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease
por: Pang, Shirley Yin-Yu, et al.
Publicado: (2022)

A Link between Autophagy and the Pathophysiology of LRRK2 in Parkinson's Disease
por: Gómez-Suaga, Patricia, et al.
Publicado: (2012)

Nonsense mutation-dependent reinitiation of translation in mammalian cells
por: Cohen, Sarit, et al.
Publicado: (2019)

Inhibiting α-Synuclein Oligomerization by Stable Cell-Penetrating β-Synuclein Fragments Recovers Phenotype of Parkinson's Disease Model Flies
por: Shaltiel-Karyo, Ronit, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_tb7n4g0k1h79anl59671k17uc1